logo
Finwire

Finwire

Apotea no longer has any publicly disclosed short seller

Citadel Advisors has reduced its short position in the online pharmacy Apotea below the public disclosure threshold and is therefore no longer a publicly disclosed short seller.

This means that there are no longer any publicly disclosed short sellers in the company. However, a total of 3.83 percent of Apotea’s capital is shorted.

The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be publicly disclosed.

Share this post

Verifierad av MonsterInsights